tiprankstipranks
Jushi Holdings (TSE:JUSH)
:JUSH
Canadian Market
Want to see TSE:JUSH full AI Analyst Report?

Jushi Holdings (JUSH) Earnings Dates, Call Summary & Reports

267 Followers

Earnings Data

Report Date
Aug 06, 2026
Before Open (Confirmed)
Period Ending
2026 (Q2)
Consensus EPS Forecast
-0.07
Last Year’s EPS
-0.08
Same Quarter Last Year
Based on 0 Analysts Ratings

Earnings Call Summary

Q1 2026
Earnings Call Date:May 12, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call conveyed a generally positive operational and strategic tone: the company delivered revenue growth, meaningful margin expansion, improved adjusted EBITDA and stronger operating cash flow while expanding wholesale distribution, SKUs and branded sales. Significant strategic positives include the federal rescheduling of medical cannabis (which could materially improve tax and operating dynamics) and a refinancing that increased liquidity without equity dilution. Offsetting concerns include modest retail growth amid pricing pressure, a widened GAAP net loss driven by elevated interest and refinancing charges, a sizable debt balance, and remaining regulatory and implementation uncertainties that affect timing of upside. On balance, the operational improvements and regulatory tailwinds meaningfully outweigh the near-term financial and execution risks.
Company Guidance
Management's guidance focused on capital deployment, liquidity and the expected benefits of federal rescheduling: for 2026 they expect maintenance CapEx of ~$4–5M, growth CapEx of ~$5–8M (total CapEx $9–13M), with the majority of construction-related spending likely shifting to 2027; the company ended Q1 with ~$42.3M cash, $222.1M of debt subject to repayment (excluding $21.5M disputed promissory notes), and completed a $160M first‑lien term loan (4% OID, 12.5% coupon, 36‑month interest‑only) that added $13.7M of incremental liquidity and carries a single minimum‑liquidity covenant; Q1 operating metrics included revenue of $66.4M (+$2.6M, +4% YoY), retail $57.9M, wholesale $8.6M, gross profit $29.9M (45% margin vs 40.4% LY), adjusted EBITDA $11.4M (17.2% vs 15.4% LY), net loss $19.8M, cash from operations $8.6M, interest expense $10.4M, and a $5M loss on debt — and management highlighted that rescheduling (medical sales ~60% of 2025 revenue) should remove Section 280E disallowance, lowering future tax expense subject to Treasury/DEA implementation and possible retroactive relief.
Modest Revenue Growth
Q1 2026 revenue of $66.4M, up 4% year-over-year from $63.8M (+$2.6M). Retail revenue $57.9M (vs $56.8M prior year) and wholesale revenue $8.6M (vs $7.0M prior year, +22.2%).
Margin Expansion and Profitability Metrics
Gross profit of $29.9M representing a 45.0% gross margin vs 40.4% in prior year (increase of ~4.6 percentage points). Adjusted EBITDA of $11.4M (17.2% margin) vs $9.8M (15.4% margin) in prior year (improved by $1.6M and +1.8pp margin).
Operational and Product Momentum
Improvements in product quality and production volumes across grower-processor footprint; introduction of 567 new SKUs (a 45% YoY increase) and record quarterly third-party packaged goods sales; Flower Foundry and Hijinks achieved mid- to high-single-digit revenue and unit growth YoY.
Wholesale Distribution Expansion
Added 32 new dispensary customers in the quarter (20 in Massachusetts, 8 in Ohio), supporting wholesale growth and expanded distribution in key markets.
Improved Operating Cash Flow and Liquidity
Cash flows from operations of $8.6M vs $7.5M prior year (+$1.1M, ~+14.7%). Ended the quarter with approximately $42.3M of cash and $13.7M of incremental liquidity from refinancing.
Strategic Refinancing Strengthened Balance Sheet
Completed $160M first-lien senior secured term loan (4% OID, 12.5% coupon, interest-only for 36 months) to repay prior debt, increase liquidity, and eliminate equity dilution; CEO increased personal capital participation.
Major Regulatory Milestone — Federal Rescheduling
Final order effective April 28 rescheduling state-licensed medical cannabis to Schedule III; expected removal of Section 280E deduction disallowance for state licensees, with medical sales representing ~60% of 2025 revenue—potential material long-term tax and operating benefits.
Market-Specific Wins and Expansion Opportunities
Retail performance strength in Ohio and Virginia (including 4 new Ohio dispensaries since Q1 2025), strong 4/20 results (net sales, units, orders up YoY), and favorable Massachusetts regulatory change increasing retail license cap from 3 to 6, creating consolidation/scale opportunities.

Jushi Holdings (TSE:JUSH) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

TSE:JUSH Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Aug 06, 2026
2026 (Q2)
-0.07 / -
-0.083
May 12, 2026
2026 (Q1)
- / -0.14
-0.124-11.11% (-0.01)
Mar 31, 2026
2025 (Q4)
-0.07 / -0.14
-0.124-11.11% (-0.01)
Nov 04, 2025
2025 (Q3)
-0.07 / -0.17
-0.11-50.00% (-0.06)
Aug 05, 2025
2025 (Q2)
-0.08 / -0.08
-0.014-500.00% (-0.07)
May 08, 2025
2025 (Q1)
-0.07 / -0.12
-0.1240.00% (0.00)
Mar 06, 2025
2024 (Q4)
-0.06 / -0.08
-0.12433.33% (+0.04)
Nov 07, 2024
2024 (Q3)
-0.05 / -0.11
-0.15227.27% (+0.04)
Aug 07, 2024
2024 (Q2)
-0.07 / -0.01
-0.09785.71% (+0.08)
May 09, 2024
2024 (Q1)
-0.08 / -0.12
-0.083-50.00% (-0.04)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

TSE:JUSH Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
May 12, 2026
C$0.69C$0.68-1.45%
Mar 31, 2026
C$0.73C$0.72-1.37%
Nov 04, 2025
C$0.85C$0.84-1.18%
Aug 05, 2025
C$0.87C$0.86-1.15%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Jushi Holdings (TSE:JUSH) report earnings?
Jushi Holdings (TSE:JUSH) is schdueled to report earning on Aug 06, 2026, Before Open (Confirmed).
    What is Jushi Holdings (TSE:JUSH) earnings time?
    Jushi Holdings (TSE:JUSH) earnings time is at Aug 06, 2026, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is TSE:JUSH EPS forecast?
          TSE:JUSH EPS forecast for the fiscal quarter 2026 (Q2) is -0.07.